Manager, Corporate Strategy & Business Development

PharmaEssentia U.S.A.•Burlington, MA

1d•$110,000 - $140,000

About The Position

The Company: It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity at PharmaEssentia USA. Join us, and let’s transform lives, together. PharmaEssentia USA Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved in Europe and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taipei Exchange (6446) and are expanding our global presence with operations in the U.S., Japan, and China, along with a world-class biologics production facility in Taichung. Position Overview: The Manager, Corporate Strategy and Business development supports PharmaEssentia’s enterprise, portfolio, and disease-area strategies through rigorous analytical work, market and competitive research, and high-quality deliverable preparation. Reporting to the Associate Director / Director, Corporate Strategy, this role serves as a core analytical engine within the Strategy team. The ideal candidate is an early-career strategist with strong problem-structuring ability and analytical rigor—comparable to a top-performing Business Analyst or Associate at a leading management consulting firm. This individual will contribute across strategic projects, business development due diligence, and portfolio governance, with significant exposure to senior leadership. Success in this role requires sharp quantitative skills, intellectual curiosity about biopharma markets and science, strong attention to detail, and the ability to synthesize complex information into clear, executive-ready outputs.

Requirements

Bachelor’s degree required; advanced degree preferred (MBA, MS, MPH, or life sciences degree).
2–5 years of relevant experience in management consulting (MBB or top-tier strategy firm strongly preferred), biopharma strategy, corporate development, or investment banking / healthcare equity research.
Strong analytical and quantitative skills, including proficiency in financial modeling, market sizing, and data synthesis.
Solid understanding of (or strong eagerness to learn) drug development, clinical evidence interpretation, and biopharma commercial dynamics.
Advanced proficiency in PowerPoint and Excel; ability to produce polished, executive-quality materials.
Excellent written and verbal communication skills with strong attention to detail.
Structured thinker who can break down ambiguous problems into logical, actionable components.
Self-starter comfortable operating in a fast-paced, dynamic biotech environment with evolving priorities.

Responsibilities

Support enterprise and therapeutic-area strategy projects by conducting market research, competitive landscaping, and data analysis under the direction of senior team members.
Structure and execute discrete analytical workstreams within larger strategic initiatives, delivering well-organized findings and preliminary recommendations.
Build and maintain models, frameworks, and databases that underpin strategic decision-making (e.g., competitive benchmarking, market sizing, scenario analysis).
Monitor industry developments, scientific publications, competitor actions, and market trends to proactively surface insights for the team.
Conduct research and analysis to support commercial due diligence on potential BD targets, including market assessments, competitive positioning, and unmet need analysis.
Build and refine financial models, including revenue forecasts, P&L scenarios, and rNPV analyses; compile benchmarking data on comparable deal terms (milestone/royalty structures, upfront payments, licensing economics) to support deal evaluation and term sheet review.
Prepare data rooms, information requests, and background materials for BD evaluations; coordinate diligence logistics including scheduling KOL consultations, advisor calls, and management meetings.
Synthesize clinical, commercial, and financial data into structured summaries and appendices for investment committee materials.
Maintain and curate the BD target landscape using databases (e.g., PitchBook, Evaluate) and industry intelligence; run initial screens against strategic criteria and prepare target profiles for leadership review.
Support the portfolio review process by gathering cross-functional inputs, organizing data, and preparing meeting materials and pre-reads.
Maintain and update portfolio dashboards, KPI trackers, and decision-support tools used by senior leadership.
Track portfolio milestones, clinical readouts, and competitive developments to keep the team’s knowledge base current.
Work closely with colleagues across R&D, Clinical, Commercial, Medical, BD, Regulatory, and Finance to gather data and align on analytical inputs.
Participate in cross-functional working groups and contribute analytical perspectives to team discussions.
Draft and refine PowerPoint presentations, memos, and analytical exhibits for executive and Board-level audiences.
Ensure accuracy, visual clarity, and logical flow in all deliverables, applying structured storytelling principles.
Support preparation of materials for Executive Team meetings, Board sessions, and strategy off-sites.